Lindsey Zubritsky
AuthID: R-00F-CMG
1
TÃTULO: Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer.
AUTORES: Allan Lipton; Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Koestler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman;
PUBLICAÇÃO: 2012, FONTE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 15
AUTORES: Allan Lipton; Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Koestler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman;
PUBLICAÇÃO: 2012, FONTE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 15
INDEXADO EM: 
WOS
WOS2
TÃTULO: Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer
AUTORES: Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Kstler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman; Allan Lipton;
PUBLICAÇÃO: 2012, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 30
AUTORES: Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Kstler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman; Allan Lipton;
PUBLICAÇÃO: 2012, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 30
INDEXADO EM: WOS
WOS